At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
MagStim Rapid2 Transcranial Magnetic Simulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of Transcranial Magnetic Stimulation in the Treatment of Non-epileptic Seizures
In Brief
A clinical study evaluating MagStim Rapid2 Transcranial Magnetic Simulation for Nonepileptic Seizures. Completed, enrolled 10 participants.
Detailed Summary
The purpose of this study is to investigate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) - a form of non-invasive brain stimulation - to decrease the frequency of psychogenic non-epileptic seizure (PNES) episodes in patients with PNES.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNonepileptic Seizures
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJun 2016
First PostedJun 2016
Primary CompletionApr 2019
Study CompletionSep 2019
TodayJul 2026
First PostedJun 13, 2016
Enrollment StartJun 1, 2016
Primary CompletionApr 1, 2019
Study CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 10.1 years ago
Interventions
MagStim Rapid2 Transcranial Magnetic Simulationdevice
A non-invasive method of brain stimulation